PPAR-γ partial agonists in disease-fate decision with special reference to cancer S Ballav, B Biswas, VK Sahu, A Ranjan, S Basu Cells 11 (20), 3215, 2022 | 17 | 2022 |
Synergistic combination of ritonavir and cisplatin as an efficacious therapy in human cervical cancer cells: a computational drug discovery and in vitro insight D Swami, P Mudaliar, YS Bichu, V Kumar Sahu, S Devarajan, S Basu, ... Journal of Biomolecular Structure and Dynamics 41 (12), 5802-5816, 2023 | 3 | 2023 |
Image processing: An early detection tool for Alzheimer’s disease S Ballav, B Biswas, S Dey, VK Sahu, S Basu Smart Diagnostics for Neurodegenerative Disorders, 99-136, 2024 | 2 | 2024 |
Dietary flavonoids as modulators of non-coding RNAs in hormone-associated cancer S Dey, B Biswas, S Ballav, VK Sahu, A Ranjan, S Basu Food Chemistry Advances 2, 100321, 2023 | 2 | 2023 |
AI Techniques and IoT Applications Transforming the Future of Healthcare VK Sahu, A Ranjan, MK Paul, S Nagar, S Devarajan, J Aich, S Basu Revolutionizing Healthcare Through Artificial Intelligence and Internet of …, 2023 | 1 | 2023 |
Identification of Novel PPAR-β/δ Agonists from Kaempferol, Quercetin, and Resveratrol Derivatives by Targeting Cancer: An Integrative Molecular Docking and Dynamics Simulation … SB Sangeeta Ballav, Kiran Bharat Lokhande, Vishal Kumar Sahu, Rohit Singh ... Letters in Drug Design & Discovery, 2023 | | 2023 |
miRVim: Three-dimensional miRNA Structure Data Server VK Sahu, AS Parida, A Ranjan, S Basu bioRxiv, 2023.11. 29.569154, 2023 | | 2023 |